Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma
1 other identifier
interventional
363
1 country
1
Brief Summary
The investigators propose to evaluate a novel diagnostic approach for Kaposi's sarcoma (KS) that may be eventually deployed with portable, point-of-care techniques. This approach features confocal microscopy. The investigators will compare this new approach with the gold standard of histology from a traditional skin punch biopsy (which is standard of care) to determine the sensitivity and specificity of portable confocal microscopy in diagnosing KS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2017
CompletedFirst Posted
Study publicly available on registry
February 13, 2017
CompletedStudy Start
First participant enrolled
March 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedOctober 26, 2020
October 1, 2020
3 years
February 9, 2017
October 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of diagnosing Kaposi sarcoma using the smartphone confocal microscopy
Confocal microscopy images obtained from the skin lesion will be compared with the corresponding histologic images. Diagnostic accuracy will be tested. No clinical decisions will be made based on confocal microscopy images.
Approximately 20 minutes (10 minutes for in vivo imaging)
Study Arms (1)
Smartphone confocal microscopy imaging
EXPERIMENTALSubject's skin lesion will be imaged with the smartphone confocal microscopy.
Interventions
Imaging of skin lesion using the smartphone confocal microscopy
Eligibility Criteria
You may qualify if:
- i. ≥ 18 years old ii. Clinically suspected KS iii. Presence of suspected KS lesions in areas which are considered safe to biopsy by the Ugandan providers, which means all areas of the skin except for the mouth and eye.
You may not qualify if:
- i. Presence of suspected KS lesions exclusively on the mouth or eye unless clinical specialists trained in biopsy of the mouth or eye are available locally to biopsy the mouth or eye. Oral and eye sites would typically only be biopsied when clinical diagnosis has proved to be problematic and definitive diagnosis is needed to inform a treatment plan.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- National Institutes of Health (NIH)collaborator
- Infectious Diseases Institute, Ugandacollaborator
Study Sites (1)
Infectious Diseases Institute
Kampala, Uganda
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dongkyun Kang, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Dermatology
Study Record Dates
First Submitted
February 9, 2017
First Posted
February 13, 2017
Study Start
March 10, 2017
Primary Completion
February 28, 2020
Study Completion
February 28, 2020
Last Updated
October 26, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share